Publications by authors named "Mahmoud Agami"

Claim this Profile
N
Novel furanone-based anticancer agents: Design, synthesis, Hsp90 inhibition, in vivo antitumor activity and pharmacokinetic studies.
Gina N Tageldin, Hisham A Nematalla, Yomna M Hesham, Ahmed F El-Yazbi, Mahmoud A Agami

Eur J Med Chem· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitigation of thromboinflammation by rivaroxaban ameliorates metabolic and structural manifestations of metabolic dysfunction-associated steatohepatitis in rats: Comparison to other antithrombotic drugs.
Basant Rageh, Marium Shamaa, Mahmoud Agami, Ahmed F El-Yazbi, Ahmed Wahid

J Pharmacol Exp Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mannosylated fisetin/carveol lipid nanocapsules: brain-targeted dual therapy for modulation of epileptogenesis and cognitive deficits.
Julie R Youssef, Nabila A Boraie, Fatma A Ismail, Basant A Bakr, Eman A Allam, Mahmoud A Agami

Drug Deliv Transl Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the impact of bioactive peptides from fermented Milk proteins: A review with emphasis on health implications and artificial intelligence integration.
Hosam M Habib, Rania Ismail, Mahmoud Agami, Ahmed F El-Yazbi

Food Chem· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-Target Glitazones for Modulating Peroxisome Proliferator-Activated Receptor-γ, Cyclooxygenase-2, and Carbonic Anhydrases for the Management of Metabolic Dysfunction.
Perihan A Elzahhar, Hisham A Nematalla, Malak A Abouayana, El Sayed H El Ashry, Mahmoud Balbaa, Mahmoud A Agami

ACS Pharmacol Transl Sci· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel thiazolones for the simultaneous modulation of PPARγ, COX-2 and 15-LOX to address metabolic disease-associated portal inflammation.
Mai S El-Shoukrofy, Azza Ismail, Reem H Elhamammy, Sherien A Abdelhady, Rasha Nassra, Mahmoud A Agami

Eur J Med Chem· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positive impact of DPP-4 or SGLT2 inhibitors on mild cognitive impairment in type 2 diabetes patients on metformin therapy: A metabolomic mechanistic insight.
Shams T Osman, Waziha Purba, Oluwatosin Daramola, Md Mostofa Al Amin Bhuiyan, Judith Nwaiwu, Mahmoud A Agami

Biomed Pharmacother· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Experimental Strategies to Study l-Type Amino Acid Transporter 1 (LAT1) Utilization by Ligands.
Johanna Huttunen, Mahmoud Agami, Janne Tampio, Ahmed B Montaser, Kristiina M Huttunen

Molecules· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LC-MS bioanalysis of targeted nasal galantamine bound chitosan nanoparticles in rats' brain homogenate and plasma.
Mahmoud Agami, Rasha A Shaalan, Saied F Belal, Marwa A A Ragab

Anal Bioanal Chem· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galantamine nanoparticles outperform oral galantamine in an Alzheimer's rat model: pharmacokinetics and pharmacodynamics.
Samar O El-Ganainy, Mennatallah A Gowayed, Mahmoud Agami, Passant Mohamed, Marwa Belal

Nanomedicine (Lond)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis